Mednow to Present at the H.C. Wainwright 24th Annual Global Investment Conference
12 Septiembre 2022 - 6:00AM
Business Wire
Mednow Inc. (“Mednow'' or the “Company”)
(TSXV:MNOW) (OTCQX:MDNWF), Canada’s on-demand virtual pharmacy,
will participate at the H.C. Wainwright 24th Annual Global
Investment Conference on September 12-14, 2022.
The presentation will be available on demand at the H.C.
Wainwright Conference Platform for 30 days.
Mednow will be introducing its story to new potential investors
and will be providing corporate updates to those who are familiar
with the Company.
Management will also participate in one-on-one and group
meetings with institutional investors. For more information about
the conference or to request a one-on-one meeting, please contact a
H.C. Wainwright sales representative.
About Mednow Inc. Mednow is
a healthcare technology company offering virtual access with a high
standard of care. Designed with accessibility and quality of care
in mind, Mednow.ca provides virtual pharmacy and telemedicine
services as well as doctor home visits through an interdisciplinary
approach to healthcare that is focused on the patient experience.
Mednow’s services include free at-home delivery of medications, a
user-friendly interface for easy upload, transfer, and refill of
prescriptions, access to healthcare professionals through an
intuitive chat experience, a specialized PillSmart™ system that
packages prescriptions and vitamins by date and time, and doctor
consultations.
To learn more, follow Mednow on Facebook, Twitter, LinkedIn, and
Instagram, or visit our website at www.mednow.ca/.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION
This release includes certain statements and information that
may constitute forward-looking information within the meaning of
applicable Canadian securities laws. All statements in this news
release, other than statements of historical facts, including
statements regarding future estimates, plans, objectives, timing,
assumptions or expectations of future performance, including
without limitation, the statement regarding the intention to
continue to execute Mednow's plan for a national presence across
Canada; and to expand its geographical reach to become a household
name in Canadian healthcare. Generally, forward-looking statements
and information can be identified by the use of forward-looking
terminology such as “intends” or “anticipates”, or variations of
such words and phrases or statements that certain actions, events
or results “may”, “could”, “should”, “would” or “occur”.
Forward-looking statements are based on certain material
assumptions and analysis made by the Company and the opinions and
estimates of management as of the date of this press release,
including that the Company will obtain the approvals required to
execute its expansion plans, that general economic and market
conditions will not change in an adverse manner, political and
regulatory stability, stability in financial and capital markets
and that the Company’s operations will not be adversely impacted by
COVID-19. These forward-looking statements are subject to known and
unknown risks, uncertainties and other factors that may cause the
actual results, level of activity, performance or achievements of
the Company to be materially different from those expressed or
implied by such forward-looking statements or forward-looking
information. Important factors that may cause actual results to
vary, include, without limitation (a) public health crises such as
the COVID-19 pandemic may adversely impact the Company’s business
and operations; (b) the volatility of global capital markets; (c)
unanticipated costs; and (d) risks relating to the extent and
duration of the conflict in Eastern Europe and its impact on global
markets. Although management of the Company has attempted to
identify important factors that could cause actual results to
differ materially from those contained in forward-looking
statements or forward-looking information, there may be other
factors that cause results not to be as anticipated, estimated or
intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward-looking
statements and forward-looking information. Readers are cautioned
that reliance on such information may not be appropriate for other
purposes. The Company does not undertake to update any
forward-looking statement, forward-looking information or financial
out-look that are incorporated by reference herein, except in
accordance with applicable securities laws.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220912005112/en/
Investor Relations Contact:
Benjamin Ferdinand, Chief Financial Officer ir@mednow.ca
1.855.686.6300
Mednow (TSXV:MNOW)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Mednow (TSXV:MNOW)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025